ロード中...
Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
This cohort study examines whether PBRM1 alterations are associated with response to immune checkpoint inhibitor treatment in patients with metastatic clear cell renal cell carcinoma.
保存先:
| 出版年: | JAMA Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Medical Association
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735411/ https://ncbi.nlm.nih.gov/pubmed/31486842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.3158 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|